---
title: "azapropazone - Gout"
sidebar: mydoc_sidebar
permalink: azapropazonegout.html
toc: false 
---

{% include image.html file="azapropazonegout.png" alt="azapropazonegout" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D001032 | Azapropazone | Drug |
| UniProt:P23219 | Prostaglandin G/H synthase 1 | Protein |
| UniProt:P35354 | Prostaglandin G/H synthase 2 | Protein |
| MESH:D011453 | Prostaglandins | ChemicalSubstance |
| GO:0006954 | Inflammation | BiologicalProcess |
| MESH:D010146 | Pain | Disease |
| MESH:D006073 | Gout | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Azapropazone | DECREASES ACTIVITY OF | Prostaglandin G/H Synthase 1 |
| Azapropazone | DECREASES ACTIVITY OF | Prostaglandin G/H Synthase 2 |
| Prostaglandin G/H Synthase 1 | INCREASES ABUNDANCE OF | Prostaglandins |
| Prostaglandin G/H Synthase 2 | INCREASES ABUNDANCE OF | Prostaglandins |
| Prostaglandins | POSITIVELY CORRELATED WITH | Inflammation |
| Inflammation | CAUSES | Pain |
| Pain | MANIFESTATION OF | Gout |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB07402#mechanism-of-action](https://go.drugbank.com/drugs/DB07402#mechanism-of-action){:target="_blank"}